Session Datesort descending
Oncology Biosimilar in Europe, the United States, and Japan: Update from the National Cancer Institute's R01 Funded Southern Network on Adverse Reactions Safety (SONAR) Program 07/31/2020 - 8:00am to 9:00am EDT
Metastatic Colon Cancer 09/11/2020 - 8:00am to 9:00am EDT
Immunotherapy of Lung Cancer 09/18/2020 - 8:00am to 9:00am EDT
Treatment Options in Oligometastatic Prostate Cancer 09/25/2020 - 8:00am to 9:00am EDT
When the Pain is so Acute or if I think that I’m going to Die: Health Care Seeking Behaviors and Experiences of Transgender and Gender Diverse (TGD) People in an Urban Area 10/02/2020 - 8:00am to 9:00am EDT
“What’s new in the treatment of advanced and early stage colorectal cancer? A lot!” 10/09/2020 - 8:00am to 9:00am EDT
Anthracycline Induced Cardiomyopathy in patient with history of breast cancer 10/16/2020 - 8:00am to 9:00am EDT
Job Loss After Treatment for Breast Cancer 10/23/2020 - 8:00am to 9:00am EDT
Role of local therapy and Her2 targeted therapy beyond the 1st line in a relapsed Her2+ breast cancer patient 10/30/2020 - 8:00am to 9:00am EDT
Predictive Models of Disease and Treatment Toxicity: Personalizing Cancer Screening and Quantifying Radiotherapy Effects on the Brain 11/06/2020 - 8:00am to 9:00am EST

Pages